©The Author(s) 2019.
World J Gastroenterol. Sep 21, 2019; 25(35): 5266-5282
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5266
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5266
Table 1 Baseline patient characteristics
| Variable | Number (n) | Percent (%) | |
| Age | 60.1 ± 15.4 | 53 | 100 |
| Gender | |||
| Male | 31 | 58.5 | |
| Female | 22 | 41.5 | |
| Race | |||
| White | 33 | 62.3 | |
| Others | 20 | 37.7 | |
| Grade | |||
| I | 18 | 34.0 | |
| II | 16 | 30.2 | |
| III | 14 | 26.4 | |
| IV | 5 | 9.4 | |
| Stage | |||
| I | 5 | 9.4 | |
| II | 25 | 47.2 | |
| III | 22 | 41.5 | |
| IV | 1 | 1.9 |
- Citation: Chen QF, Li W, Wu PH, Shen LJ, Huang ZL. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2019; 25(35): 5266-5282
- URL: https://www.wjgnet.com/1007-9327/full/v25/i35/5266.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i35.5266